Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

235 projects found matching your search criteria :

  1. Expression of selenoproteins and NRF2-modulated genes in bladder cancer ethiology and disease process

    Call: OPUS 3 , Panel: NZ5

    Principal investigator: dr hab. Edyta Wiesława Reszka

    INSTYTUT MEDYCYNY PRACY IM.PROF.DR MED.JERZEGO NOFERA W ŁODZI

  2. Study of the effect of 17-beta estradiol on expression of gene encoding hypoxia inducible factor - 1 alpha (HIF-1 alpha)...

    Call: PRELUDIUM 3 , Panel: NZ5

    Principal investigator: dr Agnieszka Anna Rawłuszko-Wieczorek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski I

  3. Follicular thyroid cancer somatic mutations profiling with massively parallel sequencing method. Sanger and next-generat...

    Call: PRELUDIUM 2 , Panel: NZ5

    Principal investigator: dr Bartosz Stefan Wojtaś

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  4. Activity evaluation of procaryotic TA modules in a dual-component model of cancer therapy

    Call: PRELUDIUM 2 , Panel: NZ5

    Principal investigator: Łukasz Janusz Wieteska

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu; Zakład Biochemii Medycznej

  5. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr hab. Ewelina Piktel

    Uniwersytet Medyczny w Białymstoku

  6. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  7. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  8. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  9. Molecular factors and pathomechanism of cancer-associated cachexia.

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Marcin Tomasz Skrzypski

    Gdański Uniwersytet Medyczny

  10. ERβ-mediated autophagy in colorectal cancer and its impact on carcinogenesis

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Julia Maria Lipowicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  11. Profiling of the stroma by spatial transcriptomics in aid of prognostication in FGFR2-mediated luminal breast cancer

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Julia Maria Sołek-Siejka

    Uniwersytet Medyczny w Łodzi

  12. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Katarzyna Anna Malarz

    Politechnika Śląska

  13. Neutrophil-targeted immune response as an effective approach in immunotherapyof gastrointestinal cancers

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Damian Jacenik

    Uniwersytet Łódzki

  14. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  15. Proteomic predictors of metastasis in colorectal cancer – a validation study

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Anna Wojakowska

    Instytut Chemii Bioorganicznej PAN

  16. The Prognostic Utility of Circulating Tumor Cells (CTCs) Derived from the Portal Vein in Operable Colorectal Cancer Pati...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Claudia Dompé

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  17. Cellular senescence as a new mechanism in development and progression of head and neck cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: prof. Michał Mateusz Masternak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  18. Defining the transcriptional and epigenetic state of tumor cells with increased plasticity and the epithelial-endothelia...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Kobielak

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  19. In search for DNA methylation aberrations associated with susceptibility to ovarian cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Malwina Magdalena Suszyńska

    Instytut Chemii Bioorganicznej PAN

  20. To be or not to be modified: the role of single m6A sites of long noncoding RNAs in breast cancer

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Elżbieta Wanowska

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  21. The role of oxidative stress, inflammation, disorders of purine metabolism, urea cycle and angiogenesis at the molecular...

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Paulina Wigner-Jeziorska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  22. Protease-induced neutrophilic networks in cancer development.

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Danuta Teresa Bryzek

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  23. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  24. Novel aspects of the mechanisms of vascular toxicity of tyrosine kinase inhibitors: studies on their proinflammatory act...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Tomasz Krzysztof Prajsnar

    Uniwersytet Jagielloński, Wydział Biologii

  25. Increasing sensitivity to immunotherapy in lung cancer via immunostimulation and modulation of tumor microenvironment

    Call: SONATA BIS 13 , Panel: NZ5

    Principal investigator: dr Urszula Oleksiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  26. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  27. The mechanism of competition of mutant p53 gain-of-function and major oncogene CMYC in gastric cancer.

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Marcin Mikołaj Grochowski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  28. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  29. Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  30. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polska Akademia Nauk

  31. Investigating the anti-cancerous effect of antioxidant extract from spent coffee grounds on the functioning of normal an...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Adrianna Maria Piasek

    Politechnika Warszawska, Wydział Chemiczny

  32. The study of the effect of hypoxia on the metabolism of exogenous ferritin and its role in the regulation of free iron i...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: dr Małgorzata Maria Kubiak

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Centrum Immunoterapii Komórkowych

  33. Determining the frequency of occurrence and defining the most appropriate screening test for anal intraepithelial neopla...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Michał Zygmunt Brzeziński

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej, Zakład Propedeutyki Onkologii

  34. Assessing ovarian cancer molecular heterogeneity by NMR-based metabolomics, spatially resolved transcriptomics and metab...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Maria Bożena Sokół

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  35. Ultrasensitive profiling of mutations driving tumorigenesis in hereditary syndromes associated with tumor suppressor gen...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr Katarzyna Klonowska

    Instytut Chemii Bioorganicznej PAN

  36. Investigating the mechanisms of epithelial/mesenchymal plasticity and metastasis.

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr Anna Agnieszka Marusiak

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  37. Dissecting the regulatory interplay between proteases and protein kinases in acute lymphoblastic leukemia using mass cyt...

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  38. Determination of the SNAIL1 transcription factor effect on biology cancer stem cells in rhabdomyosarcoma model

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: prof. Marcin Marek Majka

    Uniwersytet Jagielloński, Collegium Medicum

  39. Identifying angiogenic and metabolic biomarkers in endometriosis-associated ovarian cancer using photoacoustic imaging a...

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Monika Anna Golińska

    Uniwersytet Medyczny w Łodzi

  40. Precise molecular characterization of circulating tumour cells in patients with triple negative breast cancer using high...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Stefano Volinia

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

  41. Role of microparticles derived from platelets and cancer cells in colorectal cancer progression – how to stop them or tu...

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: prof. Maria Anna Kowalska

    Instytut Biologii Medycznej PAN

  42. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  43. Oncogene competition - a new interplay mechanism of mutant p53 with CMYC and mutant KRAS in human cancers.

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Dawid Włodzimierz Walerych

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  44. Role of the PARP1/HPF1 complex in the conferring of resistance to doxorubicin in triple negative breast cancer

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Magdalena Alicja Strachowska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  45. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Dawid Dariusz Dorna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  46. Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  47. Intrinsic tumour radiosensitivity as a marker of chemoradiotherapy-induced immunogenic effects in rectal cancer

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Zuzanna Maria Nowicka

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  48. The role of MTARC2 protein-related metabolism changes in the intestinal tumorigenesis

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Michał Marek Mikula

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  49. Local and systemic Tryptophan metabolites as gastric cancer biomarkers

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Kinga Ożga

    Katolicki Uniwersytet Lubelski Jana Pawła II

  50. MicroRNA expression as a dissemination factor in colon cancer stage pT2-4N0

    Call: OPUS 2 , Panel: NZ5

    Principal investigator: dr Marcin Skrzypski

    Gdański Uniwersytet Medyczny, Wydział Lekarski